Evidence map›Paper›PMID 35345799›Full record

ArticleComputational intelligence and neuroscience2022

Predicting Breast Cancer Based on Optimized Deep Learning Approach.

Hager Saleh, Sara F Abd-El Ghany, Hashem Alyami, Wael Alosaimi

Open access · hybridAbstract read
In one paragraph

Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hager SalehFaculty of Computers and Artificial Intelligence, South Valley University, Hurghada, Egypt.ORCID https://orcid.org/0000-0002-7758-0811
Sara F Abd-El GhanyFaculty of Computing and Information, Luxor University, Luxor, Egypt.ORCID https://orcid.org/0000-0001-8362-4350
Hashem AlyamiDepartment of Computer Science, College of Computers and Information Technology, Taif University, P. O. Box 11099, Taif 21944, Saudi Arabia.
Wael AlosaimiDepartment of Information Technology, College of Computers and Information Technology, Taif University, P. O. Box 11099, Taif 21944, Saudi Arabia.ORCID https://orcid.org/0000-0002-6940-9483
Taif University · SASouth Valley University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a dangerous disease with a high morbidity and mortality rate. One of the most important aspects in breast cancer treatment is getting an accurate diagnosis. Machine-learning (ML) and deep learning techniques can help doctors in making diagnosis decisions. This paper proposed the optimized deep recurrent neural network (RNN) model based on RNN and the Keras-Tuner optimization technique for breast cancer diagnosis. The optimized deep RNN consists of the input layer, five hidden layers, five dropout layers, and the output layer. In each hidden layer, we optimized the number of neurons and rate values of the dropout layer. Three feature-selection methods have been used to select the most important features from the database. Five regular ML models, namely decision tree (DT), support vector machine (SVM), random forest (RF), naive Bayes (NB), and

Indexed as

Breast NeoplasmsDeep LearningBayes TheoremFemaleHumansMachine LearningSupport Vector Machine

Identifiers

PMID35345799
PMCPMC8957426
OpenAlexW4220976903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.